FindTrial
Sign In

To study the Effectiveness of Oral Nutrition Supplement in Obese Population.â??

Observational Study: Effectiveness of Vidaslim® in Obese Population.â??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036636
Enrollment
125
Registered
2021-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Signutra Inc
Lead Sponsor
Signutra Inc
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: o Subjects with abdominal obesity: Waist circumference >= 102 cm and >= 88 cm, in men and women, respectively and BMI >=30.0 kg/m2

Exclusion criteria

Exclusion criteria: o Subjects not capable of understanding the informed consent. o Subjects who are on lipid lowering treatment with statins, fibrates, etc. with a known dose change over the latest 3 months (changes not allowed during the trial) o Presence of metabolic chronic disease, including type 2 diabetes (HbA1c >6.5) or hypothyroidism. o Obesity secondary to other underlying diseases such as Cushingâ??s syndrome, hypothyroidism, etc. o Treatment with corticosteroids as well as other drugs known to significantly influence body weight, such as GLP-1 agonists.

Design outcomes

Primary

MeasureTime frame
- To determine efficacy of Vidaslim® in weight loss among obese population. - To determine safety and compliance of Vidaslim® in weight loss among obese population.Timepoint: 0 8 16 weeks—

Secondary

MeasureTime frame
- To determine safety and compliance of Vidaslim® in weight loss among obese population.Timepoint: 0 8 16 weeks—

Countries

India

Contacts

Public ContactDr Sanjay Kalra

Bharti Hospital

info@mediception.com9896048555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026